NHS England Drug Tariff Part IX Wound Care Products RFI

NHS England is undertaking a review of the current processes and commercial models which support the prescribing and supply of wound products listed in Part IX of the Drug Tariff. This review is guided by the National Wound Care Strategy Programme recommendations to address unwarranted variation, improve consistency, and ensure the best possible outcomes for patients and value for the NHS. As part of this review, we are seeking feedback and information on current arrangements to help inform the future strategy. The information gathered will inform a national strategy supporting and promoting standardisation, improved collection and use to drive improvement, education and product management across the NHS.

Please note NHS England is utilising an electronic system (Atamis) to manage this RFI and communicate with suppliers. Accordingly, there will be no hard copy documents issued to suppliers and all communications with NHS England including the submission of RFI responses will be conducted via Atamis using the following link: https://health-family.force.com/login

If not already registered, please create an Atamis account using this link https://health-family.force.com/login

Please note there is no fee for registering on Atamis.

If you experience any technical issues, then support from Atamis can be obtained here:

1. Submit a request through the Atamis Help Centre

2. Email directly at …@atamis.co.uk

3. Call support on 0800 0988 201 08:00-18:00 Monday - Friday

Upon logging in please search for C396014 – “NHS England Drug Tariff Part IX Wound Care Products RFI” and follow the instructions contained in the supplier instructions.

Lots

This procurement was divided into 1 lots, each awarded separately.

Notice Amendments

Changes the buyer published to this notice after it first appeared.